Literature DB >> 20145189

Differential inhibition of protein translation machinery by curcumin in normal, immortalized, and malignant oral epithelial cells.

Nitin Chakravarti1, Humam Kadara, Do-Jun Yoon, Jerry W Shay, Jeffrey N Myers, Dafna Lotan, Nahum Sonenberg, Reuben Lotan.   

Abstract

Curcumin has shown some promise in the prevention of oral carcinogenesis by mechanism(s) that are still not completely resolved. Messenger RNA translation is mediated in eukaryotes by the eIF4F complex composed of eukaryotic translation initiation factors eIF4E, eIF4G, and eIF4A. Overexpression of some of these components or the inactivation of initiation repressor proteins (4E-BP1) has been implicated in cancer development including oral carcinogenesis by affecting cell survival, angiogenesis, and tumor growth and invasion. In this study, we examined the possibility that curcumin affects the translational machinery differently in normal, immortalized normal, leukoplakia, and malignant cells. Curcumin treatment in vitro inhibited the growth of immortalized oral mucosa epithelial cells (NOM9-CT) and the leukoplakia cells (MSK-Leuk1s) as well as in the UMSCC22B and SCC4 cells derived from head and neck squamous cell carcinoma. Curcumin only exerted minor effects on the growth of normal oral epithelial cells (NOM9). In the immortalized, leukoplakia, and cancer cells, curcumin inhibited cap-dependent translation by suppressing the phosphorylation of 4E-BP1, eIF4G, eIF4B, and Mnk1, and also reduced the total levels of eIF4E and Mnk1. Our findings show that immortalized normal, leukoplakia, and malignant oral cells are more sensitive to curcumin and show greater modulation of protein translation machinery than the normal oral cells, indicating that targeting this process may be an important approach to chemoprevention in general and for curcumin in particular.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20145189      PMCID: PMC2833226          DOI: 10.1158/1940-6207.CAPR-09-0076

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  44 in total

1.  Hierarchical phosphorylation of the translation inhibitor 4E-BP1.

Authors:  A C Gingras; B Raught; S P Gygi; A Niedzwiecka; M Miron; S K Burley; R D Polakiewicz; A Wyslouch-Cieszynska; R Aebersold; N Sonenberg
Journal:  Genes Dev       Date:  2001-11-01       Impact factor: 11.361

2.  Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

Authors:  A L Cheng; C H Hsu; J K Lin; M M Hsu; Y F Ho; T S Shen; J Y Ko; J T Lin; B R Lin; W Ming-Shiang; H S Yu; S H Jee; G S Chen; T M Chen; C A Chen; M K Lai; Y S Pu; M H Pan; Y J Wang; C C Tsai; C Y Hsieh
Journal:  Anticancer Res       Date:  2001 Jul-Aug       Impact factor: 2.480

Review 3.  Anticancer potential of curcumin: preclinical and clinical studies.

Authors:  Bharat B Aggarwal; Anushree Kumar; Alok C Bharti
Journal:  Anticancer Res       Date:  2003 Jan-Feb       Impact factor: 2.480

4.  Effects of sodium butyrate on growth, differentiation, and apoptosis in head and neck squamous carcinoma cell lines.

Authors:  A Gillenwater; C P Zou; M Zhong; R Lotan
Journal:  Head Neck       Date:  2000-05       Impact factor: 3.147

Review 5.  Molecular mechanisms of translation initiation in eukaryotes.

Authors:  T V Pestova; V G Kolupaeva; I B Lomakin; E V Pilipenko; I N Shatsky; V I Agol; C U Hellen
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

6.  Translation initiation factor eIF-4G is immunogenic, overexpressed, and amplified in patients with squamous cell lung carcinoma.

Authors:  C Bauer; I Diesinger; N Brass; H Steinhart; H Iro; E U Meese
Journal:  Cancer       Date:  2001-08-15       Impact factor: 6.860

7.  Analysis of surgical margins with the molecular marker eIF4E: a prognostic factor in patients with head and neck cancer.

Authors:  C O Nathan; S Franklin; F W Abreo; R Nassar; A De Benedetti; J Glass
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

8.  Overexpression of the eukaryotic translation initiation factor 4G (eIF4G-1) in squamous cell lung carcinoma.

Authors:  Christine Bauer; Nicole Brass; Isabel Diesinger; Klaus Kayser; Friedrich A Grässer; Eckart Meese
Journal:  Int J Cancer       Date:  2002-03-10       Impact factor: 7.396

9.  Phosphorylation of eucaryotic translation initiation factor 4B Ser422 is modulated by S6 kinases.

Authors:  Brian Raught; Franck Peiretti; Anne-Claude Gingras; Mark Livingstone; David Shahbazian; Greg L Mayeur; Roberto D Polakiewicz; Nahum Sonenberg; John W B Hershey
Journal:  EMBO J       Date:  2004-04-08       Impact factor: 11.598

Review 10.  The mRNA cap-binding protein eIF4E in post-transcriptional gene expression.

Authors:  Tobias von der Haar; John D Gross; Gerhard Wagner; John E G McCarthy
Journal:  Nat Struct Mol Biol       Date:  2004-06       Impact factor: 15.369

View more
  19 in total

1.  Rational combination with PDK1 inhibition overcomes cetuximab resistance in head and neck squamous cell carcinoma.

Authors:  Haiquan Lu; Yang Lu; Yangyiran Xie; Songbo Qiu; Xinqun Li; Zhen Fan
Journal:  JCI Insight       Date:  2019-10-03

2.  Therapeutic potential of curcumin in gastrointestinal diseases.

Authors:  Sigrid A Rajasekaran
Journal:  World J Gastrointest Pathophysiol       Date:  2011-02-15

3.  Synthesis, evaluation of cytotoxic properties of promising curcumin analogues and investigation of possible molecular mechanisms.

Authors:  Brian C Jordan; Bhavna Kumar; Ramasamy Thilagavathi; Arti Yadhav; Pawan Kumar; Chelliah Selvam
Journal:  Chem Biol Drug Des       Date:  2017-07-18       Impact factor: 2.817

4.  Induction of Glucocorticoid-induced Leucine Zipper (GILZ) Contributes to Anti-inflammatory Effects of the Natural Product Curcumin in Macrophages.

Authors:  Jessica Hoppstädter; Nina Hachenthal; Jenny Vanessa Valbuena-Perez; Sebastian Lampe; Ksenia Astanina; Michael M Kunze; Stefano Bruscoli; Carlo Riccardi; Tobias Schmid; Britta Diesel; Alexandra K Kiemer
Journal:  J Biol Chem       Date:  2016-09-14       Impact factor: 5.157

5.  Cetuximab reverses the Warburg effect by inhibiting HIF-1-regulated LDH-A.

Authors:  Haiquan Lu; Xinqun Li; Zhongguang Luo; Jie Liu; Zhen Fan
Journal:  Mol Cancer Ther       Date:  2013-08-06       Impact factor: 6.261

6.  Biological and therapeutic activities, and anticancer properties of curcumin.

Authors:  Donatella Perrone; Fatima Ardito; Giovanni Giannatempo; Mario Dioguardi; Giuseppe Troiano; Lucio Lo Russo; Alfredo DE Lillo; Luigi Laino; Lorenzo Lo Muzio
Journal:  Exp Ther Med       Date:  2015-09-17       Impact factor: 2.447

7.  The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines.

Authors:  Stacey L Fossey; Misty D Bear; Jiayuh Lin; Chenglong Li; Eric B Schwartz; Pui-Kai Li; James R Fuchs; Joelle Fenger; William C Kisseberth; Cheryl A London
Journal:  BMC Cancer       Date:  2011-03-28       Impact factor: 4.430

Review 8.  Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma.

Authors:  Reason Wilken; Mysore S Veena; Marilene B Wang; Eri S Srivatsan
Journal:  Mol Cancer       Date:  2011-02-07       Impact factor: 27.401

9.  Spice up the hypertension diet - curcumin and piperine prevent remodeling of aorta in experimental L-NAME induced hypertension.

Authors:  Livia Hlavačková; Andrea Janegová; Olga Uličná; Pavol Janega; Andrea Cerná; Pavel Babál
Journal:  Nutr Metab (Lond)       Date:  2011-10-17       Impact factor: 4.169

10.  Curcumin as therapeutics for the treatment of head and neck squamous cell carcinoma by activating SIRT1.

Authors:  An Hu; Jing-Juan Huang; Rui-Lin Li; Zhao-Yang Lu; Jun-Li Duan; Wei-Hua Xu; Xiao-Ping Chen; Jing-Ping Fan
Journal:  Sci Rep       Date:  2015-08-24       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.